European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Nordmark Pharma GmbH, Uetersen, Germany

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Nordmark Pharma GmbH
Bibitec Gesellschaft für Prozessentwicklung mbH

Identification

Ut
District Court of Pinneberg HRB 15550 PI
Ut
District Court of Bielefeld HRB 37876
Lei
529900PJ7W5JHLAN3C67
EUID
DEX1321R.HRB15550PI

Address

Pinnauallee 4, 25436 Uetersen, Germany
Bielefeld, Germany

Corporate purpose

The development, manufacture and distribution of medicinal products and active substances as well as dietary, cosmetic and similar products.

Financials

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Persons

Marketing & Tech

Network

Loading network
CSV export

Quarterly Exports in CSV

Now available in CSV format and optimized for applications in AI and Analytics:
North Data's quarterly exports have become the industry standard for company information.

Publications

1 Oct 2025 in Sat
State Aid (€100,000 - €500,000): Germany - Evaluation plan for the block exempted R&D tax incentive scheme "Forschungszulagengesetz"
5 Sept 2025
Word figurative mark: “Nordmark“
1 Sept 2025
Annual report for the year ending 31/12/2024 · Balance sheet for 31/12/2024 · Shareholder (11 companies)
23 Aug 2025
Wordmark: “Fynor“
20 Aug 2025 via Nordmark Arzneimittel Holding GmbH & Co. KG
Shareholder: Nordmark Arzneimittel Holding GmbH & Co. KG
24 Jul 2025
No longer Authorized signatory (ppa) (3)
5 Jun 2025
Figurative mark: “Figurative“
28 Apr 2025
Wordmark: “Nordmark“
24 Oct 2024 via Nordmark Arzneimittel Holding GmbH & Co. KG
Shareholder: Nordmark Arzneimittel Holding GmbH & Co. KG
12 Sept 2024
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023 · Earnings statement for 31/12/2023 · Shareholdings (11 companies)
23 Jul 2024
Managing Director: Jörg Arne Clemens · No longer Authorized signatory (ppa) (3)
7 Jun 2024
Managing Director: Henning Mallwitz, Richard Nagorny
27 Mar 2024
Patent: A Computer-Implemented Method for Monitoring and Documenting Process Steps in a Laboratory and a Respective Device
15 Feb 2024
Figurative mark: “Figurative“
15 Feb 2024
Wordmark: “Nordmark“
12 Dec 2023
Authorized signatory (ppa): Andrea Bretschneider · Share­holder agreement
4 Dec 2023
Original document: “Gesellschaftsvertrag / Satzung / Statut“
19 Sept 2023
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022 · Shareholdings (11 companies)
7 Aug 2023 via Nordmark Arzneimittel Holding GmbH & Co. KG
Shareholder: Nordmark Arzneimittel Holding GmbH & Co. KG
31 May 2023
No longer Managing Director: Detlev Baumeister
10 Feb 2023
Authorized signatory (ppa): Michael Kurdum
2 Jan 2023
Patent: Culture Medium for Cultivating Hathewaya Histolytica (or Clostridium Histolyticum) and the Production of ONE or More Proteases
Year 2022 in Dpmam
28 trademark filings: Enzynorm, Eurozyme, Euzyme, Helopan, More-N-Zyme, New-N-Zyme, Nordmark, PROHEPAR, Proheparum, Thrombophob …
Year 2022 in Dpmap
6 patent filings: Verfahren zur Reduzierung der Belastung von Pankreatin mit Mikroorganismen …
16 Aug 2022 via Nordmark Arzneimittel Holding GmbH & Co. KG
Shareholder: Nordmark Arzneimittel Holding GmbH & Co. KG
9 Jun 2022
Authorized signatory (ppa): Petra Knieling
9 Jun 2022
List of board members
9 Jun 2022
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021 · Shareholdings (11 companies)
10 May 2022
Original document: “Liste der Aufsichtsratsmitglieder“
6 Apr 2022
Managing Director: Jörn Tonne
1 Mar 2022
Managing Director: Detlev Baumeister, Jörn Tonne
18 Nov 2021 via Nordmark Arzneimittel Holding GmbH & Co. KG
Shareholder: Nordmark Arzneimittel Holding GmbH & Co. KG
1 Oct 2021
Patent: Wässrige Lösung von Burlulipase umfassend Kalziumionen
15 Sept 2021
Authorized signatory (ppa): Niels Schlaack · No longer Authorized signatory (ppa) (4)
6 Jul 2021
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020 · Shareholdings (10 companies)
28 Jun 2021 via Nordmark Arzneimittel Holding GmbH & Co. KG
Shareholder: Nordmark Arzneimittel Holding GmbH & Co. KG
Year 2021 in Dpmam
1 word figurative mark: Euzym, Hippozym, More-N-Zyme, NORLIPASE, Nordmark, Norzyme, Proheparum, Thrombophob …
12 May 2021
Patent: Orodispersible Tablet Comprising Burlulipase and ITS Pharmaceutical Composition
31 Mar 2021 as Normark Pharma GmbH
Utility patent: Pankreatin-Pellets, insbesondere Pankreatin-Mikropellets
3 Mar 2021
Bekanntmachung der Geschäftsführung der Nordmark Pharma GmbH über die Zusammensetzung des Aufsichtsrats gemäß § 27 EGAktG, § 97 Abs. 1 AktG
1 Mar 2021 via NORAX AG also 26/02/2021
Control, Control, Acquisition, Spin-off: NORAX AG
25 Feb 2021 via Nordmark Pensionsverwaltungs GmbH also 23/02/2021
Control, Spin-off: Nordmark Pensionsverwaltungs GmbH
24 Feb 2021 via Viprinex Research AG also 23/02/2021
Control, Control, Spin-off: Viprinex Research AG
1 Feb 2021 via Nordmark Arzneimittel Holding GmbH & Co. KG
Acquisition, Spin-off: Nordmark Arzneimittel Holding GmbH & Co. KG
1 Feb 2021
Acquisition: Nordmark Arzneimittel GmbH & Co. KG · Spin-off: Nordmark Arzneimittel GmbH & Co. KG · Capital: €10M · Share­holder agreement · Corporate Purpose
29 Jan 2021
Original document: “Liste der Gesellschafter“
25 Jan 2021
Authorized signatory (ppa) (9) · Proxy policy
23 Dec 2020 as Bibitec Gesellschaft für Prozessentwicklung mbH
Change of headquarters: Nordmark Pharma GmbH
22 Dec 2020
MD: Detlev Baumeister, Jörg Arne Clemens, Jörn Tonne · No longer MD: Dirk Lütkemeyer · ppa (1) · Change of headquarters: Bibitec Gesellschaft für Prozessentwicklung mbH · Address · Capital: €100,000
22 Dec 2020
Original document: “Gesellschaftsvertrag / Satzung / Statut“
22 Dec 2020
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
15 Dec 2020
Original document: “Gesellschaftsvertrag / Satzung / Statut“
9 Dec 2020
Patent: Pharmaceutical Composition Containing AT Least ONE Digestive Enzyme for USE in Artificial Nutrition
24 Aug 2020 via Nordmark Arzneimittel Holding GmbH & Co. KG
Shareholder: Nordmark Arzneimittel GmbH & Co. KG
18 Aug 2020 as Bibitec Gesellschaft für Prozessentwicklung mbH
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019
10 Aug 2020 via Nordmark Arzneimittel Holding GmbH & Co. KG
Shareholder: Nordmark Arzneimittel GmbH & Co. KG
24 Sept 2019 via Nordmark Arzneimittel Holding GmbH & Co. KG
Shareholder: Nordmark Arzneimittel GmbH & Co. KG
6 Sept 2019 as Bibitec Gesellschaft für Prozessentwicklung mbH
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018
21 May 2019 via Nordmark Arzneimittel Holding GmbH & Co. KG
Shareholder: Nordmark Arzneimittel GmbH & Co. KG
14 Feb 2019
Patent: Chromatographic Purification of AT Least ONE Enzyme Selected From the Group Consisting of Collagenase Type I, Collagenase Type II, Neutral Protease, and Clostripain
9 Oct 2018 via Nordmark Arzneimittel Holding GmbH & Co. KG
Shareholder: Nordmark Arzneimittel GmbH & Co. KG
Year 2018 in Dpmap
7 patent filings: Wässrige Lösung von Burlulipase Umfassend Kalziumionen …
29 Aug 2018 as Bibitec Gesellschaft für Prozessentwicklung mbH
Authorized signatory (ppa) (1)
28 Jun 2018 as Bibitec Gesellschaft für Prozessentwicklung mbH
Authorized signatory (ppa) (1)
15 Jun 2018 as Bibitec Gesellschaft für Prozessentwicklung mbH
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017
7 Jun 2018 via Nordmark Arzneimittel Holding GmbH & Co. KG
Shareholder: Nordmark Arzneimittel GmbH & Co. KG
5 Mar 2018
Patent: Pharmaceutical Composition Comprising a Core of Pancreatin and a Coating Comprising a Lipase
5 Dec 2017 via Nordmark Arzneimittel Holding GmbH & Co. KG
Shareholder: Nordmark Arzneimittel GmbH & Co. KG
7 Nov 2017 as Bibitec Gesellschaft für Prozessentwicklung mbH
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016
16 Oct 2017 via Nordmark Arzneimittel Holding GmbH & Co. KG
Shareholder: Nordmark Arzneimittel GmbH & Co. KG
7 Jul 2017 as Bibitec Gesellschaft für Prozessentwicklung mbH
Word figurative mark: “BIBITEC“
7 Jul 2017 as Bibitec Gesellschaft für Prozessentwicklung mbH
Wordmark: “Bibitec“
Year 2017 in Dpmap
8 patent filings: Verfahren zur Reduzierung der Belastung von Pankreatin mit Mikroorganismen …
8 Dec 2016 as Bibitec Gesellschaft für Prozessentwicklung mbH
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015
7 Dec 2016 via Nordmark Arzneimittel Holding GmbH & Co. KG
Shareholder: Nordmark Arzneimittel GmbH & Co. KG
22 Nov 2016 via Nordmark Arzneimittel Holding GmbH & Co. KG
Shareholder: Nordmark Arzneimittel GmbH & Co. KG
17 May 2016
Wordmark: “Lifrinor“
11 Feb 2016 as Bibitec Gesellschaft für Prozessentwicklung mbH
No longer Managing Director: Manfred Kurfürst
10 Dec 2015 as Bibitec Gesellschaft für Prozessentwicklung mbH
Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014
5 Nov 2015 via Nordmark Arzneimittel Holding GmbH & Co. KG
Shareholder: Nordmark Arzneimittel GmbH & Co. KG
Year 2015 in Dpmap
4 patent filings: Verfahren zur Reduzierung der Belastung von Pankreatin mit Mikroorganismen …
4 Nov 2015 via Nordmark Arzneimittel Holding GmbH & Co. KG
Shareholder: Nordmark Arzneimittel GmbH & Co. KG
6 May 2015
Wordmark: “Nordmark“
24 Dec 2014
Patent: Method for Reducing the Viral and Microbial Load of Extracts Containing Solids and Obtained From Animal Pancreas
17 Dec 2014 via Nordmark Arzneimittel Holding GmbH & Co. KG
Shareholder: Nordmark Arzneimittel GmbH & Co. KG
11 Dec 2014
Figurative mark: “Figurative“
5 Nov 2014 via Nordmark Arzneimittel Holding GmbH & Co. KG
Shareholder: Nordmark Arzneimittel GmbH & Co. KG
23 Oct 2014
Figurative mark: “Figurative“
1 Oct 2014 as Bibitec Gesellschaft für Prozessentwicklung mbH
Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013
11 Dec 2013
Patent: Pancreatin Pellets, in Particular Pancreatin Micropellets and Method for Producing Same
21 Nov 2013 as Bibitec Gesellschaft für Prozessentwicklung mbH
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012
10 Jan 2013 via Science Holding GmbH
Shareholder: Science Holding GmbH
3 Jul 2012 as Bibitec Gesellschaft für Prozessentwicklung mbH
Managing Director: Detlev Baumeister, Manfred Kurfürst, Dirk Lütkemeyer · No longer Managing Director (2)
1 Jun 2012
Managing Director: Detlev Baumeister, Manfred Kurfürst, Dirk Lütkemeyer · No longer Managing Director (2)
26 Apr 2012
Utility patent: Neue Verwendung einer pharmazeutischen Zusammensetzung, enthaltend Ancrod
1 Mar 2012
Utility patent: Neue Verwendung einer pharmazeutischen Zusammensetzung, enthaltend Ancrod
19 Jan 2012
Utility patent: Neue Verwendung einer pharmazeutischen Zusammensetzung, enthaltend Ancrod
9 Jan 2012 via Science Holding GmbH
Shareholder: Science Holding GmbH
14 Oct 2011 as Bibitec Gesellschaft für Prozessentwicklung mbH
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010
14 Oct 2011
Wordmark: “NORZYME“
14 Jul 2011 as Normark Pharma GmbH
Utility patent: Pankreatin-Pellets, insbesondere Pankreatin-Mikropellets
9 Jun 2011 as Normark Pharma GmbH
Utility patent: Pankreatin-Pellets, insbesondere Pankreatin-Mikropellets
30 Mar 2011 as Normark Pharma GmbH
Utility patent: Pankreatin-Pellets, insbesondere Pankreatin-Mikropellets
17 Feb 2011 via Science Holding GmbH
Shareholder: Science Holding GmbH
19 Aug 2010 as Bibitec Gesellschaft für Prozessentwicklung mbH
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009
Year 2010 in Dpmap
4 patent filings: Pharmazeutisches Präparat Enthaltend Lipase Bakteriellen Ursprungs …
9 Jun 2010
Address
9 Apr 2010 as Bibitec Gesellschaft für Prozessentwicklung mbH
Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008
15 Jan 2010 as Bibitec Gesellschaft für Prozessentwicklung mbH
Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006
27 Aug 2009
Patent: Verfahren zur Verringerung der viralen und mikrobiellen Belastung feststoffhaltiger biologischer Extrakte
31 Jul 2009 as Bibitec Gesellschaft für Prozessentwicklung mbH
Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007
1 Jan 2009 as Bibitec Gesellschaft für Prozessentwicklung mbH
Public funding (€167,960): Antibody-Selective Materials for Downstream Processing: Selectivity by Epitope Imprinting, Host-Guest Chemistry and Twitter Surface Modifications, TP 3
1 Sept 2008 as Bibitec Gesellschaft für Prozessentwicklung mbH
Managing Director (1)
19 Aug 2008 as Bibitec Gesellschaft für Prozessentwicklung mbH
No longer Control: NewLab BioQuality AG · No longer Control: NewLab BioQuality AG
8 Aug 2008
No longer Control: NewLab BioQuality AG · No longer Control: NewLab BioQuality AG
14 Oct 2004
Capital: €100,000 · Share­holder agreement · Corporate Purpose
10 Nov 2003
Control · Control
19 Aug 2003
No longer Managing Director (1)
7 Jul 2003 as Bibitec Gesellschaft für Prozessentwicklung mbH
Reg­is­tra­tion · Managing Director (3) · Capital: 50,000 DEM · Seat: Bielefeld, Germany · Legal form · Name: Bibitec Gesellschaft für Prozessentwicklung mbH · Corporate Purpose
There are no publications matching your search.

Mentions

12 Sept 2025 in Ler
Direct parent: Nordmark Arzneimittel Holding GmbH & Co. KG
12 Sept 2025 in Ler
Ultimate parent: Nordmark Arzneimittel Holding GmbH & Co. KG
14 Jul 2022 in Hrdk also 14/12/2020
Bibitec Verwaltungs GmbH: “Liste der Gesellschafter“
13 Dec 2021 in Hrcdd
Limited Partner: Demora Grundstücksverwaltungsgesellschaft mbH & Co. Vermietungs KG
Year 2021 in Hrdk
Shareholdings (5 companies)
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "Nordmark Pharma GmbH, Uetersen, Germany" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.